For centuries, the fundamental clockwork of human life was dictated by the rising and setting of the sun, an elemental force that shaped our biology, governed our sleep patterns, and naturally fueled our bodies with vital nutrients. In our modern era, however, this ancestral connection has been profoundly severed. We have transitioned into an indoor species, spending upwards of ninety percent of our days insulated inside climate-controlled Offices, homes, and vehicles, illuminated by the artificial blue glow of computer screens rather than the natural warmth of the atmosphere. This seismic lifestyle shift has exacted a quiet but devastating toll on global public health, precipitating a silent epidemic of vitamin D deficiency that currently impacts more than one billion people worldwide. The consequences of this progressive sun-depletion are far-reaching, directly linking our indoor isolation to a host of debilitating physical and psychological ailments, including seasonal affective disorder (SAD), severe bone density loss, compromised immune systems, and heightened risks of cardiovascular disease. The irony is particularly acute in tech-centric sanctuaries like the Pacific Northwest, where brilliant minds build the software of the future inside sprawling corporate campuses while the world outside remains shrouded in gloom for three-quarters of the year. It is against this backdrop of chronic light deprivation that Seattle-area startup Solius Labs has stepped forward, driven by an ambitious mission to rebuild our biological bridge to the sun by synthesizing the healing properties of natural sunlight and delivering them safely, predictably, and conveniently right to our living room walls.
The journey to bring this healing light into the average home required a dramatic evolution in both company leadership and engineering philosophy. Founded in 2013, Solius Labs originally approached the problem of light deficiency with a heavy, clinical footprint, designing massive, futuristic walk-in kiosks resembling high-tech tanning booths. While these early cabins successfully demonstrated their therapeutic value in clinical trials and public pilot installations—such as their landmark 2018 deployment in a Vancouver, British Columbia pharmacy—they remained too large, expensive, and logistically complex to reach the wider public. A pivotal transformation occurred in 2023 when Chris Kiple took the reins as CEO, bringing with him a seasoned leadership team from Bothell-based Ventec Life Systems, a medical manufacturer famous for partnering with General Motors to rapidly scale up critical ventilator production during the darkest days of the COVID-19 pandemic. Drawing upon this intensive background in scaling complex life-support systems, Kiple recognized that the true potential of Solius lay in democratizing the technology. He set out to thoroughly recapitalize the business, successfully raising a $23 million Series A funding round championed by Lauder Partners, alongside an array of forward-thinking venture capital funds, family offices, and private investors. This capital infusion allowed Kiple to pivot the company’s engineering focus away from institutional kiosks toward a compact, elegant, and highly accessible consumer format, transforming a room-sized medical machine into a domestic design object.
This relentless focus on miniaturization and user-centric design ultimately culminated in the creation of the Solius Pro, a sleek, wall-mounted light therapy device about the size of a standard large laptop computer that brings clinical-grade wellness into the comfort of the home. Retailing at $2,995, the Solius Pro is engineered to seamlessly blend into a modern living space or professional office, hanging unobtrusively on the wall until it is activated via a dedicated, intuitive smartphone application. When a user prepares for their weekly session, the device utilizes a proprietary, patent-pending scanning system to read and analyze their specific skin characteristics in real time. Based on this precise physiological assessment, the Solius Pro customizes and delivers a highly targeted dose of Ultraviolet B (UVB) light at a precise wavelength of 293 nanometers directly to the user’s back. By focusing entirely on this narrow, optimal wavelength, the device triggers the body’s natural synthesis of vitamin D with extraordinary efficiency, requiring only a single, painless session of less than five minutes per week. This hyper-targeted delivery system represents a massive technological leap over traditional broad-spectrum light exposure, maximizing the therapeutic benefits of UVB radiation while keeping the overall exposure time to an absolute minimum, thereby eliminating the tedious and time-consuming regimens historically associated with clinical light therapies.
The core breakthrough of the Solius Pro lies in how it successfully navigates the delicate, often hazardous relationship between human skin and ultraviolet radiation, a task that historically required the direct, vigilant oversight of seasoned clinical practitioners. Traditionally, UVB light therapies have been confined to specialized dermatology clinics, where they are utilized as powerful tools to manage localized chronic skin conditions such as eczema, psoriasis, and vitiligo. The primary barrier to home adoption has always been safety; because human skin types respond in vastly different ways to ultraviolet wavelengths, an incorrect dosage can easily result in painful burns and tissue damage, while an underdose yields no therapeutic benefit whatsoever. Solius Labs elegantly bypassed this hurdle by inventing an automated, intelligent sensor system that effectively acts as an onboard dermatologist, measuring skin density and pigmentation to calculate a safe, optimal exposure limit for every individual without requiring human intervention. This engineering triumph enabled the company to secure crucial regulatory validation, with the Food and Drug Administration (FDA) clearing the Solius Pro as a Class II medical device under a newly established, dedicated product code—SGZ—specifically created to govern this class of technology. According to official FDA filings, this clearance formally validates the system’s capacity to safely stimulate the body’s endogenous production of vitamin D in adults aged twenty-two and older, establishing a new gold standard for consumer-facing phototherapy.
The market’s response to this revolutionary home wellness system has been overwhelmingly enthusiastic, signaling a massive, pent-up demand for practical, science-backed solutions to modern indoor living. Ahead of its official commercial launch, Solius has already secured more than 1,000 pre-orders for the Solius Pro, with manufacturing pipelines humming in anticipation of initial consumer shipments scheduled to begin in July. The company’s business strategy stretches far beyond affluent consumer households; Kiple envisions a multifaceted distribution ecosystem that spans a diverse array of medical, corporate, and recreational spaces. The Solius Pro is uniquely positioned to thrive not only in family living rooms, but also in traditional primary care practices, progressive dermatology clinics, corporate wellness centers, and high-end spas. To support this broad market rollout and maintain their rapid trajectory of innovation, Solius Labs has grown to just over twenty dedicated employees at its Bainbridge Island headquarters, and is actively recruiting top-tier talent across critical engineering, quality assurance, regulatory compliance, sales, and marketing roles. This localized economic growth is a testament to the company’s deep commitment to building a sustainable, high-impact enterprise that benefits both its immediate community and the global population at large.
Ultimately, the story of Solius Labs is a deeply human narrative about reconciliation—a technological attempt to restore the ancient harmony between our biology and the natural world within the constraints of our modern lives. The irony of developing a “sunshine machine” on Bainbridge Island, where overcast skies dominate the horizon for months on end, is a poetic reality that Chris Kiple and his team embrace with open arms, recognizing that their local environment provides the ultimate proving ground for their work. It is easy to view technology as the force that drives us further away from nature, confining us to desks, isolating us behind screens, and alienating us from our circadian rhythms. Yet, with the Solius Pro, technology is instead deployed as a brilliant, restoring force, capturing the very best evolutionary benefits of the sun and packaging them into a safe, accessible, and elegantly designed home utility. By empowering individuals to reclaim their vitality, emotional balance, and physical health in just five minutes a week, Solius Labs is doing far more than shipping a premium medical appliance; they are giving us back our birthright, delivering the life-giving essence of the sun anytime, anywhere, and illuminating a healthier, more vibrant path forward for humanity.
